BID and renal cell carcinoma: We found that BID high expression was observably enriched in the immune process, while BID down-regulation was enriched in energy metabolism and cancer-related pathways, such as insulin signaling pathway, WNT signaling pathway, renal cell carcinoma, pathways in cancer, MAPK signaling pathway, etc. Metabolic changes are prevalent in several human cancer tissues.